Brief: Seegene Announces Partnership With Bio-Rad To Develop Diagnostic Testing Products For The U.S. Market
06/07/2021 11:25
July 6 (Reuters) - Seegene Inc 096530.KQ :
* SEEGENE ANNOUNCES PARTNERSHIP WITH BIO-RAD TO DEVELOP
DIAGNOSTIC
TESTING PRODUCTS FOR THE U.S. MARKET
* SEEGENE - UNDER DEAL, INTENDS TO SEEK U.S. FDA CLEARANCE
FOR
CLINICAL ASSAYS ON BIO-RAD'S REAL-TIME PCR SYSTEM 'CFX96( (TM)
)DX REAL-TIME PCR SYSTEM'
Source text for Eikon: ID:nCNWlbSRxa
Further company coverage: 096530.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seegene
See all newsBrief: Seegene To Cancel 174 Billion Won Worth Of Own Shares
Brief: Seegene Q4 Operating Profit 7 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Establishes French Subsidiary To Expand European Footprint
Brief: Seegene Q2 Operating Profit 3 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Q1 Operating Profit 14.8 Billion Won, Swings To Profit From Year Earlier